These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37652123)

  • 1. Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.
    van Prehn J; van Werkhoven CH; Skinner AM; Guery B; Dubberke ER; Kuijper EJ
    Clin Microbiol Infect; 2024 Feb; 30(2):165-169. PubMed ID: 37652123
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.
    Kunishima H; Ohge H; Suzuki H; Nakamura A; Matsumoto K; Mikamo H; Mori N; Morinaga Y; Yanagihara K; Yamagishi Y; Yoshizawa S
    J Infect Chemother; 2022 Aug; 28(8):1045-1083. PubMed ID: 35618618
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.
    Cross SJ; Morton TH; Wolf J
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S46-S51. PubMed ID: 34791397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile from intracardiac vegetation.
    Chaudhry R; Khullar S; Arif N; Sagar T; Meena D; Kumar Chowdhury U
    Anaerobe; 2021 Jun; 69():102350. PubMed ID: 33610766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.
    Rao K; Malani PN
    JAMA; 2020 Apr; 323(14):1403-1404. PubMed ID: 32150234
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children.
    Kociolek LK; Crews JD; Schwenk HT
    Curr Opin Infect Dis; 2021 Oct; 34(5):527-532. PubMed ID: 34232137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.
    Goldstein EJC; Citron DM; Gerding DN; Wilcox MH; Gabryelski L; Pedley A; Zeng Z; Dorr MB
    Clin Infect Dis; 2020 Aug; 71(4):1102-1105. PubMed ID: 31883370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of diagnostic and antimicrobial stewardship practices to improve
    Sullivan KV; Gallagher JC; Leekha S; Morgan DJ; Morita K; Rock C; Claeys KC
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):930-934. PubMed ID: 34376271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of
    Chinese Preventive Medicine Association
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):58-63. PubMed ID: 33503697
    [No Abstract]   [Full Text] [Related]  

  • 13. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides difficile and colorectal cancer: a dangerous liaison.
    Bassotti G; Stracci F; Marconi P; Fettucciari K
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):985-988. PubMed ID: 37505976
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Dasari SP; Patel MA; Saravanan V; Jha S; O'Sullivan KL; Gill HS; Acharya P; Jha P
    WMJ; 2022 Apr; 121(1):E5-E9. PubMed ID: 35442586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected Results From a Phase 2 Trial of a Microbiome Therapeutic for Clostridioides difficile Infection: Lessons for the Future.
    Young VB
    Clin Infect Dis; 2021 Jun; 72(12):2141-2143. PubMed ID: 32330238
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric Reactive Arthritis Due to
    Rand K; Yau JT; He K; Mohandas S; Reyhan I; Gutierrez Y
    Clin Pediatr (Phila); 2022 Oct; 61(9):649-653. PubMed ID: 35674059
    [No Abstract]   [Full Text] [Related]  

  • 19. A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
    Skinner AM; Tan X; Sirbu BD; Danziger LH; Gerding DN; Johnson S
    Clin Infect Dis; 2021 Sep; 73(6):1107-1109. PubMed ID: 33714998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colitis caused by Clostridioides difficile infection in a domestic dog: A case report.
    Rainha K; Lins D; Ferreira RF; Costa CL; Penna B; Endres BT; Garey KW; Domingues RMCP; Ferreira EO
    Anaerobe; 2022 Feb; 73():102511. PubMed ID: 34990816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.